GRAIL Announces Strategic Collaboration With AstraZeneca to Develop Companion Diagnostic Tests to…
Collaboration Will Leverage GRAIL’s Proprietary Methylation Platform to Identify Patients Across Multiple Tumor Types in Early Stages of Disease…